-
Ergonomist Laurie Wolf, MS, CPE, spent years teaching client companies how to reduce their workers compensation claims by implementing ergonomic interventions. But when her own employer, BJC Health Care in St. Louis, encountered claims of more than $4 million, she realized that she needed to turn her attention close to home.
-
The Occupational Safety and Health Administration (OSHA) is hanging tough on enforcement of safer needle devices, with a new information bulletin that clearly restates its prohibition against reuse of blood tube holders.
-
Smallpox preparedness needs to take a broader focus, with a registry of health care workers and others who have been previously vaccinated, an Institute of Medicine (IOM) panel has advised.1
-
Been there; done that; got stuck. Sometimes the most convincing argument for using safer needles comes from someone who didnt.
-
Figuring out how to save money is a lot easier than actually doing it. That is the lesson that Delynn Lamott, RN, MS, COHN-S, learned when she went to work for a small community hospital in Michigan.
-
Drug screening rarely comes out positive in new hires, but the screening itself may dissuade drug users from applying for jobs. The University Health Systems of Eastern Carolina in Greenville, NC, was able to make the process more cost-effective by implementing random drug screening.
-
The risk of acquiring HIV infection from occupational exposures may be even lower than the three in 1,000 rate that is commonly cited.
-
The Centers for Disease Control and Prevention in Atlanta has recommended surveillance of health care workers who have contact with severe acute respiratory syndrome (SARS) patients or their environment of care.
-
On March 24, Carol Tough, RN, had to make a decision between going to work and possibly risk getting a mysterious new disease, or quitting the career shed had for 17 years. She went to work.
-
First responders and law enforcement officers began receiving smallpox vaccines in some states, even while cardiac events associated with the vaccine continued to draw scrutiny.
